General Practice · San Juan, PR
NPI
1083612527
Since 2005
Specialty
General Practice
Code 208D00000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
Po Box 13821
San Juan, PR, 00908
Phone (787) 480-3000
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$3.7M
6,352 prescriptions
Company payments, 2025
$374
From 3 companies
Medicare prescription drug claims, 2024
In 2024, the drug Luis G Marquez prescribed most often to Medicare patients was Omega-3 Acid Ethyl Esters, with 266 prescriptions and refills. In total Luis G Marquez wrote 6,352 Medicare prescriptions that cost $3.7M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-04-25.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Omega-3 Acid Ethyl Esters Generic | 266 | 272 | 38 | $6,985 |
| Gabapentin Generic | 255 | 276 | 39 | $2,400 |
| Atorvastatin Calcium Generic | 246 | 268 | 36 | $1,197 |
| Montelukast Sodium Generic | 207 | 225 | 29 | $1,354 |
| Famotidine Generic | 194 | 198 | 33 | $958 |
| Losartan Potassium Generic | 192 | 220 | 30 | $1,265 |
| Tivicay Dolutegravir Sodium | 165 | 165 | 22 | $426K |
| Rosuvastatin Calcium Generic | 145 | 159 | 25 | $691 |
| Juluca Dolutegravir/Rilpivirine | 144 | 144 | 19 | $508K |
| Synthroid Levothyroxine Sodium | 122 | 140 | 20 | $6,817 |
| Lisinopril Generic | 116 | 124 | 18 | $386 |
| Metformin Hcl Generic | 116 | 132 | 16 | $395 |
| Descovy Emtricitabine/Tenofov Alafenam | 109 | 109 | 14 | $242K |
| Clonazepam Generic | 108 | 108 | 22 | $924 |
| Naproxen Generic | 108 | 117 | 16 | $759 |
Brand drugs: 1,649 claims; generic drugs: 4,657 claims; opioid claims: 110.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Luis G Marquez $374 ($374 in general payments such as food, travel and fees) from 3 companies. The largest payer was Gilead Sciences, Inc. with $188.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.